Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9603 posts found.

LisaRojkjaer100

Dr Lisa Rojkjaer, head of clinical development, MorphoSys

October 15, 2009 Research and Development appointment, morphosys, research and development

MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …
Appointment

GSK plans

October 14, 2009 Research and Development GSK

GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …
News

Merck makes Indian bioscience acquisition

October 14, 2009 Research and Development Asia, India, Merck

 Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …
News

GSK’s Avodart tackles BPH better in combination

October 14, 2009 Research and Development, Sales and Marketing GSK, bph, urology

GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …
News

Contract research news in brief

October 13, 2009 Research and Development CRO

Pharmafocus' latest round-up of contract research news includes another CRO heading into private equity hands, changing requirements for the clinicaltrials.gov …
News

Head-to-head trial favours Shire’s Fosrenol

October 8, 2009 Research and Development, Sales and Marketing fosrenol, renal

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …
News

GSK: Committed to improving UK clinical research

October 6, 2009 Research and Development GSK, GlaxoSmithKline, NHS

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …
Feature

Contract research news in brief

October 6, 2009 Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …
News

AZ signs biomarker research deal

October 5, 2009 Research and Development AZ, Cancer

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …
News

UK children recruited for H1N1 vaccine trials

October 2, 2009 Research and Development, Sales and Marketing h1n1, paediatric, vaccines

The UK has commenced a two-week swine flu vaccine trial, a month ahead of its planned programme to vaccinate 11 …
News

Quintiles opens Scottish central lab

September 28, 2009 Research and Development Quintiles, Scotland

Quintiles has opened new facilities near Edinburgh, Scotland, that more than double its ability to provide central laboratory services to …
News

Contract research news in brief

September 22, 2009 Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes an acquisition and alliance for BioClinica, accreditations for ICON …
News

Pfizer and Icagen extend pain drug deal

September 22, 2009 Research and Development Icagen, Pfizer

Pfizer has extended its existing deal with biotech Icagen, aimed at developing new treatments for pain and related disorders. Over …
News

AZ strikes drug development deal with Nektar Therapeutics

September 22, 2009 Research and Development AZ, Nektar

 AstraZeneca has licenced two anti-constipation drug development programmes from Nektar Therapeutics in a deal that could be worth more than …
News

Safety First

September 22, 2009 Research and Development, Sales and Marketing EU, US, reg, safety

A series of high-profile drug withdrawals in recent years has brought safety concerns to the fore, prompting more rigorous monitoring …
Feature
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026